Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines

Clinical Cancer Research

Volumn 5, Issue 5, 1999, Pages 1211-1218

  Sigala, Sandra ^a   Faraoni, Isabella ^b   Botticini, Daniela ^a   Paez Pereda, Marcelo ^c   Missale, Cristina ^a   Bonmassar, Enzo ^b   Spano, PierFranco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NERVE GROWTH FACTOR; RNA; TELOMERASE;

ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALE GENITAL TRACT CANCER; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD; ENZYME INDUCTION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KANGAI-1 PROTEIN; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NERVE GROWTH FACTORS; PHENOTYPE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; RNA, MESSENGER; RNA, NEOPLASM; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0032959269     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Karp, J. E., Chiarodo, A., Brawley, O., and Kelloff, G. J. Prostate cancer prevention: investigational approaches and opportunity. Cancer Res., 56: 5547-5556, 1996.
2. Stearn, M. E., and McGarvey, T. Biology of the disease. Prostate cancer: therapeutics, diagnostic and basic studies. Lab. Invest., 67: 540-552, 1992.
3. Kim, N-W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.
4. Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., Shay, J. W., and Coffey, D. S. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res., 56: 218-222, 1996.
5. Lin, Y., Uemura, H., Fujinami, K., Hosaka, M., Harada, M., and Kubota, Y. Telomerase activity in primary prostate cancer. J. Urol., 157: 1161-1165, 1997.
6. Zhang, W., Kapusta, L. R., Slingerland, J. M., and Klotz, L. H. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium. Cancer Res., 58: 619-621, 1998.
7. Shay, J. W. Telomerase in human development and cancer. J. Cell. Physiol., 173: 266-270, 1997.
8. Blackburn, E. H. Structure and function of telomeres. Nature (Lond.), 350: 569-573, 1991.
9. Harley, C. B., and Villeponteau, B. Telomeres and telomerase in aging and cancer. Curr. Opin. Genet. Dev., 5: 249-255, 1995.
10. De Lange, T. Activation of telomerase in a human tumour. Proc. Natl. Acad. Sci. USA, 91: 2882-2885, 1994.
11. Holt, S. E., Shay, J. W., and Wright, W. E. Refining the telomere-telomerase hypothesis of aging and cancer. Nat. Biotechnol., 14: 836-839, 1996.
12. Cunha, G. R. Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer (Phila.), 74: 1030-1044, 1994.
13. Djakiew, D., Tarkington, M. A., and Lynch J. H. Paracrine stimulation of polarized secretion from monolayers of a neoplastic prostatic epithelial cell line by prostatic stromal cell proteins. Cancer Res., 50: 1966-1974, 1990.
14. Harper, G. P., and Thoenen, H. Guinea pig prostate is a rich source of nerve growth factor. Nature (Lond.), 279: 160-162, 1979.
15. Djakiew, D., Delsite, R., Pflug, B., Wrathall, J., Lynch, J. H., and Onoda, M. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate. Cancer Res., 51: 3304-3310, 1991.
16. Graham, C. W., Lynch, J. H., and Djakiew, D. Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma. J. Urol., 147: 1444-1447, 1992.
17. Macgrogan, D., Saint-Andrè, J-P., and Dicou, E. Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines. J. Neurochem., 59: 1381-1391, 1992.
18. Paul, A. B., Grant, E. S., and Habib, F. K. The expression and localization of β-nerve growth factor (β-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation. Br. J. Cancer, 74: 1990-1996, 1996.
19. Chao, M. V., and Hempstead B. L. p75 and Trk. A two-receptor system. Trends Neurosci., 18: 321-326, 1995.
20. Pflug, B. R., Dionne, C., Kaplan, D. R., Lynch, J., and Djakiew, D. Expression of a Trk high affinity nerve growth factor receptor in the human prostate. Endocrinology, 136: 262-268, 1995.
21. Pflug, B. R., Onoda, M., Lynch, J. H., and Djakiew, D. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res., 52: 5403-5406, 1992.
22. Missale, C., Boroni, F., Losa, M., Giovanelli, M., Zanellato, A., Dal Toso, R., and Spano, P. F. Nerve growth factor suppresses the transforming phenotype of human prolactinomas. Proc. Natl. Acad. Sci. USA, 90: 7961-7965, 1993.
23. Missale, C., Codignola, A., Sigala, S., Finardi, A., Paez-Pereda, M., Sher, E., and Spano, P. F. Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines. Proc. Natl. Acad. Sci. USA, 95: 5366-5371, 1998.
24. Dong, J-T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., and Barrett, J. C. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Washington DC), 268: 884-886, 1995.
25. Dong, J. T., Suzuki, H., Pin, S. S., Bova, G. S., Schalken, J. A., Isaacs, W. B., Barrett, C., and Isaacs J. T. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res., 56: 4387-4390, 1996.
26. Piatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright, W. E., and Shay, J. W. Detection of telomerase activity in human cells and tumor by telomeric repeat amplification protocol. Methods Cell. Sci., 17: 1-15, 1995.
27. Chomczynski, P., and Sacchi, N. Single-step RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-163, 1989.
28. Ponte, P., Ng, S. I., Engel, J., Gunning, P., and Kedes, L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of human β-actin gene. Nucleic Acids Res., 12: 1687-1696, 1984.
29. Martin-Zanca, D., Oskam, R., Mitra, G., Copeland, T., and Barbacid, M. Molecular and biochemical characterization of the human trk proto-oncogene. Mol. Cell. Biol., 9: 24-33, 1989.
30. Johnson, D., Lanahan, A., Buck, C. R., Sehgal, A., Morgan, C., Mercer, E., Bothwell, M., and Chao, M. Expression and structure of the human NGF receptor. Cell, 47: 545-554, 1986.
31. Ledda, M. F., Adris, S., Bravo, A. I., Kairiyama, C., Bover, L., Chernajovsky, Y., Mordoh, J., and Podhajcer, O. L. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat. Med., 3: 171-176, 1997.
32. Liu, G., Shuman, M. A., and Cohen, R. L. Coexpression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int. J. Cancer, 60: 501-506, 1995.
33. Holt, S. E., Wright, W. E., and Shay, J. W. Multiple pathways for the regulation of telomerase activity. Eur. J. Cancer, 33: 761-766, 1997.
34. Ichikawa, T., Ichikawa, Y., and Isaacs, J. T. Genetic factors and metastatic potential of prostatic cancer. Cancer Surv., 11: 35-42, 1991.
35. Takaoka, A., Hinoda, Y., Satoh, S., Adachi, Y., Itoh, F., Adachi, M., and Imai, K. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene, 16: 1443-1453, 1998.
36. NGFR to trkA. J. Neurosci. Res., 51: 442-453, 1998.
37. NGFR affinity states is mediated by direct receptor interactions. Eur. J. Neurosci., 10: 890-898, 1998.
38. NTR in a human prostate epithelial tumor cell line reduces nerve growth factor-induced cell growth by activation of programmed cell death. Mol. Carcinog., 23: 106-114, 1998.
39. Dionne, C. A., Camoratto, A. M., Jani, J. P., Emerson, E., Neff, N., Vaught, J. L., Murakata, C., Djakiew, D., Lamb, J., Bova, S., George, D., and Isaacs, J. T. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587). Clin. Cancer Res., 4: 1887-1898, 1998.